Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Mapatumumab/sorafenib combination is safe in patients with advanced HCC and chronic hepatitis

Jan. 26, 2011

Recombinant PDGF-BB shows promise in tendinopathy and osteochondral defect repair

Jan. 26, 2011

Flex-590 confers chondroprotection in a model of osteoarthritis

Jan. 25, 2011

Phase I data reported on recombinant angiotensin-converting enzyme 2

Jan. 25, 2011

StronBone Sr-substituted bioactive glass implants show promise in bone grafting

Jan. 25, 2011

Interim phase II data disclosed on nimotuzumab plus irinotecan in gastric cancer

Jan. 25, 2011

Serum KL-6 level is a biomarker of prognosis in diffuse alveolar hemorrhage syndrome

Jan. 25, 2011

Parthenolide sensitizes osteosarcoma cells to radiation

Jan. 24, 2011

Combination therapies including cediranib well tolerated in patients with gastric cancer

Jan. 24, 2011

Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo

Jan. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...